The organization, which is celebrating its two-year anniversary this month, said it has delivered over 11 million vials of drugs, more than 9 million of them to patients and about 2 million to the federal stockpile to help combat drug shortages caused by the COVID-19 pandemic.
“COVID-19 is a defining moment as Civica, our supply partners and hospital pharmacists and doctors work together to meet spikes in demand for medications for COVID patients,” said Martin VanTrieste, president and CEO of Civica. “Because the Civica model includes building stockpiles or safety stocks, we have been able to meet demand in hospitals and also provide millions of doses of medicines to the U.S. Strategic National Stockpile.”
Civica said it now includes 50 health systems and serves over 30 percent of all hospital beds in the U.S. Oakland, Calif-based Kaiser Permanente was the latest health system to join Civica in June.
Civica said it plans to have 100 medications available by 2023.
“Without the ready supply of critical medications from Civica, crucial therapies for our patients could have been compromised during the worst possible time at the epicenter of the pandemic,” said Mark Pollard, vice president of professional services at New York City’s NYU Langone Health.
More articles on pharmacy:
Mylan recalls 2 drugs after label mix-up
Novartis establishes new sustainability goals
Bayer to acquire vitamin subscription company for $225M
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
